Renal Transplantation Outcomes and Treatments

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators

Nanostructured High‐Entropy Alloys with Multiple Principal Elements: Novel Alloy Design Concepts and Outcomes

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Estimating causal effects of treatments in randomized and nonrandomized studies.

Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Longitudinal Data Analysis for Discrete and Continuous Outcomes

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes